Send Inquiry
400 MG Metronidazole Tablet IP
800 INR/Unit
Product Details:
- Origin of Medicine India
- Drug Type General Medicines
- Physical Form Tablets
- Dosage 400 mg
- Storage Instructions Dry place
- Click to View more
X
400 MG Metronidazole Tablet IP Price And Quantity
- 800 INR/Unit
- 10 Unit
400 MG Metronidazole Tablet IP Product Specifications
- 400 mg
- India
- Dry place
- Tablets
- General Medicines
400 MG Metronidazole Tablet IP Trade Information
- Cash in Advance (CID)
- 5000 Unit Per Month
- 7-10 Days
- All India
Product Description
400 MG Metronidazole Tablet IP is a general medicine manufactured, exported, and supplied in India. These tablets are used for the treatment of bacterial infections and protozoal infections in the body. These tablets come in a physical form of tablets with a dosage of 400 mg. The medicine works by stopping the growth of bacteria and protozoa, and thus, helps in curing the infection. It is advised to store the tablets in a dry place away from direct sunlight.
FAQs of 400 MG Metronidazole Tablet IP:
Q: What is the use of 400 MG Metronidazole Tablet IP?
A: 400 MG Metronidazole Tablet IP is used to treat bacterial and protozoal infections in the body.Q: What is the dosage of 400 MG Metronidazole Tablet IP?
A: The dosage of 400 MG Metronidazole Tablet IP is 400 mg.Q: What is the physical form of 400 MG Metronidazole Tablet IP?
A: The physical form of 400 MG Metronidazole Tablet IP is tablets.Q: What are the storage instructions for 400 MG Metronidazole Tablet IP?
A: It is advised to store 400 MG Metronidazole Tablet IP in a dry place away from direct sunlight.Q: Is 400 MG Metronidazole Tablet IP available for export and supply?
A: Yes, 400 MG Metronidazole Tablet IP is available for export, manufacture, and supply.Enter Buying Requirement Details
Other Products in 'Pharmaceutical Tablets' category
Jackson Laboratories Pvt. Ltd.
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
